Kirkland & Ellis advised Clearwater Analytics, Goodwin Procter advised Enfusion, and Dechert advised the Special Committee of Enfusion on the deal. Clearwater Analytics (NYSE: CWAN), a...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here